On October 5, 2023, Treatment.Com International Inc. closed the transaction. The company amended the terms of the transaction and issued 2,475,000 common shares in the capital of the company at a price of CAD 0.15 per common share, for aggregate gross proceeds of up to CAD 371,250. The company has received CAD 350,234 pursuant to Regulation D and included participation from 2 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 CAD | +57.50% | +70.27% | +48.24% |
1st Jan change | Capi. | |
---|---|---|
+48.24% | 18.02M | |
-3.97% | 29.89B | |
+46.60% | 9.73B | |
+36.91% | 4.51B | |
-31.88% | 2.58B | |
-9.44% | 1.6B | |
-27.08% | 1.26B | |
-43.47% | 960M | |
+7.60% | 962M | |
-43.97% | 781M |
- Stock Market
- Equities
- TRUE Stock
- News Treatment.com AI Inc.
- Treatment.Com International Inc. announced that it has received CAD 0.37125 million in funding